Exploration of Current and New Technologies for Accuracy of Diagnosing OSA
NCT: NCT07485582 · NOT_YET_RECRUITING
Brief Summary
Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA). From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products. The purpose of this study is: 1. Products performance against PSG 2. comparison against other products, and 3. Assessments of potential new technologies
Frequently Asked Questions
What is Exploration of Current and New Technologies for Accuracy of Diagnosing OSA?
Exploration of Current and New Technologies for Accuracy of Diagnosing OSA is a clinical trial registered under NCT07485582. Current status: NOT_YET_RECRUITING.
What is the status of NCT07485582?
The current status of NCT07485582 (Exploration of Current and New Technologies for Accuracy of Diagnosing OSA) is: NOT_YET_RECRUITING.
When did Exploration of Current and New Technologies for Accuracy of Diagnosing OSA start?
Exploration of Current and New Technologies for Accuracy of Diagnosing OSA started on 2026-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.